1. Home
  2. HAE vs OII Comparison

HAE vs OII Comparison

Compare HAE & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • OII
  • Stock Information
  • Founded
  • HAE 1971
  • OII 1964
  • Country
  • HAE United States
  • OII United States
  • Employees
  • HAE N/A
  • OII N/A
  • Industry
  • HAE Medical/Dental Instruments
  • OII Oilfield Services/Equipment
  • Sector
  • HAE Health Care
  • OII Energy
  • Exchange
  • HAE Nasdaq
  • OII Nasdaq
  • Market Cap
  • HAE 2.5B
  • OII 2.3B
  • IPO Year
  • HAE 1991
  • OII N/A
  • Fundamental
  • Price
  • HAE $71.92
  • OII $23.76
  • Analyst Decision
  • HAE Strong Buy
  • OII Hold
  • Analyst Count
  • HAE 9
  • OII 4
  • Target Price
  • HAE $79.67
  • OII $25.00
  • AVG Volume (30 Days)
  • HAE 949.3K
  • OII 788.1K
  • Earning Date
  • HAE 11-06-2025
  • OII 10-22-2025
  • Dividend Yield
  • HAE N/A
  • OII N/A
  • EPS Growth
  • HAE 42.54
  • OII 73.60
  • EPS
  • HAE 3.44
  • OII 2.29
  • Revenue
  • HAE $1,327,850,000.00
  • OII $2,829,032,000.00
  • Revenue This Year
  • HAE N/A
  • OII $5.78
  • Revenue Next Year
  • HAE $6.35
  • OII $1.81
  • P/E Ratio
  • HAE $20.88
  • OII $10.30
  • Revenue Growth
  • HAE N/A
  • OII 8.71
  • 52 Week Low
  • HAE $47.32
  • OII $15.46
  • 52 Week High
  • HAE $94.99
  • OII $30.98
  • Technical
  • Relative Strength Index (RSI)
  • HAE 87.25
  • OII 52.11
  • Support Level
  • HAE $49.96
  • OII $22.13
  • Resistance Level
  • HAE $71.37
  • OII $23.59
  • Average True Range (ATR)
  • HAE 2.27
  • OII 0.93
  • MACD
  • HAE 2.60
  • OII 0.04
  • Stochastic Oscillator
  • HAE 96.93
  • OII 45.53

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

Share on Social Networks: